Related Experiment Video
Updated: Apr 27, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Cardiogenic shock
Palak Shah1, Jennifer A Cowger2
1Inova Translational Medicine Institute, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.
Insights
Cardiogenic shock, a major cause of death after myocardial infarction, requires prompt diagnosis and treatment. Management focuses on restoring blood flow, managing complications, and supporting organ function to improve survival rates.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock is the leading cause of in-hospital mortality following myocardial infarction.
- Mortality rates for cardiogenic shock exceed 50%.
Purpose of the Study:
- To outline the critical management strategies for patients experiencing cardiogenic shock post-myocardial infarction.
- To emphasize the importance of timely diagnosis and intervention.
Main Methods:
- Focus on rapid diagnosis and assessment of cardiogenic shock.
- Prioritize early revascularization to restore coronary blood flow.
- Incorporate medical therapies like inotropes and vasodilators.
- Utilize pulmonary arterial catheters selectively for hemodynamic assessment.
Main Results:
- Effective management hinges on a multi-faceted approach.
- Early revascularization is key to improving outcomes.
- Pharmacological support is crucial for the failing heart.
- Hemodynamic monitoring via pulmonary arterial catheters should be judiciously applied.
Conclusions:
- Prompt diagnosis and intervention are vital for improving survival in cardiogenic shock.
- A combination of revascularization, medical therapy, and selective monitoring optimizes patient care.
- Effective management strategies can mitigate the high mortality associated with this condition.
Abstract:
Cardiogenic shock is the most common cause of in-hospital mortality for patients who have suffered a myocardial infarction. Mortality exceeds 50% and management is focused on a rapid diagnosis of cardiogenic shock, restoration of coronary blood flow through early revascularization, complication management, and maintenance of end-organ homeostasis. Besides revascularization, inotropes and vasodilators are potent medical therapies to assist the failing heart. Pulmonary arterial catheters are an important adjunctive tool to assess patient hemodynamics, but their use should be limited to select patients in cardiogenic shock.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Introduction Cardiac Emergencies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation IV: Pharmacological Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy I: Introduction and Classification

